Charles has 23 years of experience working in infectious diseases discovery and development at major pharmaceutical companies (Roche, GSK and Pfizer) including work with HIV, HBV, HCV and HCMV. Focused on patient well-being and quality of life, Charles provides Clinical and Translational virology leadership, supporting antiviral development from candidate selection through approval and beyond. He has contributed to several successful regulatory submissions for HIV and HCMV products in EU and USA including 3 new chemical entities, one a first-in-class drug.
Previously he has led teams investigating new targets, driving and implementing strategy for both small molecules and biotherapeutics in virology and immuno-modulation-related projects. He has also performed monoclonal antibody studies in a vaccine setting and investigated the immunology of viral infections in autoimmune diseases.